DE3482374D1 - Pharmazeutische zusammensetzung mit verzoegerter abgabe. - Google Patents
Pharmazeutische zusammensetzung mit verzoegerter abgabe.Info
- Publication number
- DE3482374D1 DE3482374D1 DE8484301954T DE3482374T DE3482374D1 DE 3482374 D1 DE3482374 D1 DE 3482374D1 DE 8484301954 T DE8484301954 T DE 8484301954T DE 3482374 T DE3482374 T DE 3482374T DE 3482374 D1 DE3482374 D1 DE 3482374D1
- Authority
- DE
- Germany
- Prior art keywords
- theophylline
- total
- hours
- pharmaceutical composition
- released
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE789/83A IE55745B1 (en) | 1983-04-06 | 1983-04-06 | Sustained absorption pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3482374D1 true DE3482374D1 (de) | 1990-07-05 |
Family
ID=11018164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8484301954T Expired - Fee Related DE3482374D1 (de) | 1983-04-06 | 1984-03-22 | Pharmazeutische zusammensetzung mit verzoegerter abgabe. |
Country Status (9)
Country | Link |
---|---|
US (2) | US4663150A (de) |
EP (1) | EP0122077B1 (de) |
JP (1) | JPS59219219A (de) |
AT (1) | ATE53176T1 (de) |
BE (1) | BE899293A (de) |
CH (1) | CH660688B (de) |
DE (1) | DE3482374D1 (de) |
IE (1) | IE55745B1 (de) |
PH (1) | PH18904A (de) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
IE58246B1 (en) * | 1984-12-21 | 1993-08-11 | Byk Gulden Lomberg Chem Fab | Theophylline sustained release formulation |
GB2170104A (en) * | 1985-01-30 | 1986-07-30 | Warner Lambert Co | Coated pharmaceutical dosage forms |
GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
US4826688A (en) * | 1985-11-13 | 1989-05-02 | 501 Elan Corporation PLC. | Controlled absorption pharmaceutical formulation |
US5026709A (en) * | 1986-04-07 | 1991-06-25 | Rorer Pharmaceutical Corporation | Method for the preparation of a theophylline sustained release pharmaceutical composition and the composition prepared thereby |
IE58401B1 (en) * | 1986-06-20 | 1993-09-08 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
US5286494A (en) * | 1986-07-02 | 1994-02-15 | Schering Aktiengesellschaft | Medicinal agents with sustained action |
GB8628728D0 (en) * | 1986-12-02 | 1987-01-07 | Euro Celtique Sa | Spheroids |
IL84599A0 (en) * | 1986-12-09 | 1988-04-29 | Byk Gulden Lomberg Chem Fab | Pharmaceutical composition containing urapidil and process for the preparation thereof |
US4789549A (en) * | 1987-03-09 | 1988-12-06 | Warner-Lambert Company | Sustained release dosage forms |
CA1323833C (en) * | 1987-04-28 | 1993-11-02 | Yatindra M. Joshi | Pharmaceutical compositions in the form of beadlets and method |
US4808413A (en) * | 1987-04-28 | 1989-02-28 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions in the form of beadlets and method |
US4786509A (en) * | 1987-05-18 | 1988-11-22 | Schering Corporation | Dry sustained release theophylline oral formulation |
JPH07116044B2 (ja) * | 1987-10-16 | 1995-12-13 | エラン コーポレーション ピー エル シー | 吸収の制御されたジルチアゼム製剤並びにその製造方法及び使用 |
IE64726B1 (en) * | 1987-11-20 | 1995-08-23 | Elan Corp Plc | Pharmaceutical formulations for preventing drug tolerance |
US5296236A (en) * | 1988-09-16 | 1994-03-22 | Recordati S.A., Chemical And Pharmaceutical Company | Controlled release therapeutic system for a liquid pharmaceutical formulations |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
US5122384A (en) * | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
DE3929864A1 (de) * | 1989-09-08 | 1991-03-14 | Nordmark Arzneimittel Gmbh | Verfahren zur herstellung von theophyllin-pellets |
JPH0674206B2 (ja) * | 1989-12-28 | 1994-09-21 | 田辺製薬株式会社 | 放出制御型製剤およびその製法 |
US5162110A (en) * | 1990-12-19 | 1992-11-10 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Binding theophylline to ion exchange resins |
US5431922A (en) * | 1991-03-05 | 1995-07-11 | Bristol-Myers Squibb Company | Method for administration of buspirone |
JP3426230B2 (ja) * | 1991-05-20 | 2003-07-14 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | 複数層の制御放出処方剤 |
US5229135A (en) * | 1991-11-22 | 1993-07-20 | Prographarm Laboratories | Sustained release diltiazem formulation |
SE9202250D0 (sv) * | 1992-07-29 | 1992-07-29 | Gacell Lab Ab | Controlled release morphine preparation |
US5744164A (en) * | 1994-12-16 | 1998-04-28 | Nestec S.A. | Sustained release microparticulate caffeine formulation |
US20030215507A1 (en) * | 1996-03-25 | 2003-11-20 | Wyeth | Extended release formulation |
US20060073201A1 (en) * | 1996-03-25 | 2006-04-06 | Wyeth | Extended release formulation |
US5766623A (en) * | 1996-03-25 | 1998-06-16 | State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Compactable self-sealing drug delivery agents |
FR2758461A1 (fr) * | 1997-01-17 | 1998-07-24 | Pharma Pass | Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation |
FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
US6066339A (en) * | 1997-10-17 | 2000-05-23 | Elan Corporation, Plc | Oral morphine multiparticulate formulation |
DE19845358A1 (de) * | 1998-10-02 | 2000-04-06 | Roehm Gmbh | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US20040029959A1 (en) * | 2002-08-08 | 2004-02-12 | John Devane | Isosorbide mononitrate compositions and methods of their use |
CA2497176A1 (en) * | 2002-09-04 | 2004-03-18 | Ranbaxy Laboratories Limited | Taste masked dosage forms and processes for their preparation |
GB0227948D0 (en) * | 2002-11-29 | 2003-01-08 | Cipla Ltd | Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines |
US9107804B2 (en) | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
DE10353196A1 (de) * | 2003-11-13 | 2005-06-16 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix |
WO2005123042A1 (en) * | 2004-06-10 | 2005-12-29 | Glatt Air Techniques, Inc. | Controlled release pharmaceutical formulation |
CN101111230B (zh) * | 2005-03-29 | 2010-05-19 | 赢创罗姆有限责任公司 | 包含对活性成分具有调节释放作用的小丸的多颗粒药用形式 |
EP1743638A1 (de) | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Pharmazeutische Formulierungen von substituierten Pyrazolinderivaten |
AU2006269944A1 (en) * | 2005-07-19 | 2007-01-25 | Inverseon, Inc. | Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases |
KR101413613B1 (ko) * | 2006-01-27 | 2014-07-10 | 앱탈리스 파마테크, 인코포레이티드 | 약 염기성 선택성 세로토닌 5-ht3 차단제와 유기산을 포함하는 약물 전달 시스템 |
RU2428176C2 (ru) * | 2006-01-27 | 2011-09-10 | Юранд, Инк. | Системы доставки лекарственного средства, содержащие слабоосновные лекарственные средства и органические кислоты |
CN101484147B (zh) * | 2006-08-18 | 2015-07-08 | 赢创罗姆有限责任公司 | 对于具有水中良好溶解性的活性成分具有受控的活性成分释放性的药物组合物 |
US8133506B2 (en) * | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
US20110003005A1 (en) * | 2009-07-06 | 2011-01-06 | Gopi Venkatesh | Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
US8992898B2 (en) | 2010-04-17 | 2015-03-31 | Shannon Elizabeth Klingman | Antiperspirants and deodorants |
CA2936746C (en) | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
HUE053082T2 (hu) * | 2018-09-27 | 2021-06-28 | Inibsa Ginecologia S A | Eljárás doxilamin-szukcinát- és piridoxin-hidroklorid-tartalmú, módosított hatóanyag-leadású, több kis egységet tartalmazó, orális adagolási forma elõállítására |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2853420A (en) * | 1956-01-25 | 1958-09-23 | Lowey Hans | Ethyl cellulose coatings for shaped medicinal preparations |
US3081233A (en) * | 1960-08-08 | 1963-03-12 | Upjohn Co | Enteric-coated pilules |
NL122039C (de) * | 1960-10-20 | |||
BE636568A (de) * | 1961-01-31 | |||
US3247066A (en) * | 1962-09-12 | 1966-04-19 | Parke Davis & Co | Controlled release dosage form containing water-swellable beadlet |
NL297631A (de) * | 1963-06-03 | |||
US3949068A (en) * | 1964-02-20 | 1976-04-06 | University Of Alabama In Birmingham Medical And Educational Foundation | Pharmaceutical compositions |
US3400185A (en) * | 1965-04-08 | 1968-09-03 | Bristol Myers Co | Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof |
DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
US4016254A (en) * | 1972-05-19 | 1977-04-05 | Beecham Group Limited | Pharmaceutical formulations |
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
DE2343218C2 (de) * | 1973-08-28 | 1986-08-07 | Hoechst Ag, 6230 Frankfurt | Furosemid enthaltende Pellets |
US3906087A (en) * | 1973-09-10 | 1975-09-16 | Union Corp | Sustained release of methantheline |
US4085214A (en) * | 1976-10-18 | 1978-04-18 | Interx Research Corporation | Stable pro-drug forms of theophylline |
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
US4309406A (en) * | 1979-07-10 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4248858A (en) * | 1979-08-09 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
DE3000979A1 (de) * | 1980-01-12 | 1981-07-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue dipyridamol-retardformen und verfahren zu ihrer herstellung |
JPS56122311A (en) * | 1980-02-29 | 1981-09-25 | Eisai Co Ltd | Lasting theophylline pharmaceutical composition |
NZ196349A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered polar bioactive agents |
DE3127237A1 (de) * | 1981-07-10 | 1983-01-20 | Hoechst Ag, 6000 Frankfurt | Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung |
WO1983000284A1 (en) * | 1981-07-15 | 1983-02-03 | Key Pharma | Sustained release theophylline |
IT1153487B (it) * | 1982-04-15 | 1987-01-14 | Prophin Lab Spa | Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli |
US4415547A (en) * | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
US4710384A (en) * | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
-
1983
- 1983-04-06 IE IE789/83A patent/IE55745B1/en not_active IP Right Cessation
-
1984
- 1984-03-22 AT AT84301954T patent/ATE53176T1/de active
- 1984-03-22 EP EP84301954A patent/EP0122077B1/de not_active Expired - Lifetime
- 1984-03-22 DE DE8484301954T patent/DE3482374D1/de not_active Expired - Fee Related
- 1984-03-30 BE BE0/212666A patent/BE899293A/fr not_active IP Right Cessation
- 1984-04-04 CH CH170584A patent/CH660688B/fr unknown
- 1984-04-05 PH PH30501A patent/PH18904A/en unknown
- 1984-04-06 JP JP59068974A patent/JPS59219219A/ja active Granted
-
1986
- 1986-05-21 US US06/870,293 patent/US4663150A/en not_active Expired - Lifetime
-
1987
- 1987-01-16 US US07/003,736 patent/US4820521A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IE55745B1 (en) | 1991-01-02 |
ATE53176T1 (de) | 1990-06-15 |
JPS59219219A (ja) | 1984-12-10 |
US4663150A (en) | 1987-05-05 |
US4820521A (en) | 1989-04-11 |
EP0122077A3 (en) | 1985-09-11 |
EP0122077B1 (de) | 1990-05-30 |
JPH0466207B2 (de) | 1992-10-22 |
CH660688B (de) | 1987-06-15 |
BE899293A (fr) | 1984-07-16 |
EP0122077A2 (de) | 1984-10-17 |
PH18904A (en) | 1985-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3482374D1 (de) | Pharmazeutische zusammensetzung mit verzoegerter abgabe. | |
ATE66813T1 (de) | Arzneimittel-formulierung. | |
ATE43497T1 (de) | Pharmazeutische formulierung mit gesteuerter absorption. | |
ATE22535T1 (de) | Pharmazeutische zusammensetzungen fuer die kontinuierliche freigabe des wirkstoffes. | |
DE3773468D1 (de) | Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung. | |
ATE107857T1 (de) | Zusammensetzung mit kontrollierter freisetzung von dihydrocodein. | |
DE3773070D1 (de) | Arzneimittel mit verzoegerter freigabe in oraler dosisform. | |
AR065072A2 (es) | Una formulacion medicamentosa de pellet de difusion controlada que tiene liberacion controlada de un compuesto activo | |
DE69000881D1 (de) | 2-propylvaleriansaeure enthaltende arzneizubereitung mit verzoegerter wirkstofffreigabe. | |
DE69133623D1 (de) | Haltende neue pharmazeutische formulierungen sowie verfahren zu deren herstellung | |
NO992944L (no) | Virkestoffbµrer for avgivelse av apomorfin i munnhulen | |
ATE87201T1 (de) | Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung. | |
IT8220758A1 (it) | Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli | |
ES2194832T3 (es) | Formulaciones de ditiazem con absorcion controlada. | |
DE69121058D1 (de) | Salze von Glykosaminoglykanen mit Aminosäureester, ihre Herstellung sowie sie enthaltende pharmazeutische Zusammensetzungen | |
YU46419B (sh) | Postupak za dobivanje novog farmaceutskog preparata koji se sastoji od slojeva koji obezbedjuju kontrolisano oslobadjanje aktivne materije |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |